| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0695 | Ar-244555 | Novel inverse agonist of Mas G-protein signaling, dose-dependently inhibiting inositol 1,4,5-trisphosphate accumulation in AdMas-infected cells, and attenuating the sarcomeric organization and cell enlargement observed in Mas overexpressing myocytes |
|
| DCC0696 | Ar-a000002 | Novel 5-hydroxytryptamine 1B (5-HT 1B ) autoreceptor antagonist |
|
| DCC0697 | Ar-c117977 | Novel immunosuppressant and monocarboxylate transporter inhibitor, reducing immune responses both in vitro and in vivo, maintaining long-term graft survival, and inducing operational tolerance |
|
| DCC0698 | Ar-c141990 | Novel inhibitor of lactate transporters (monocarboxylate transporters; MCTs) |
|
| DCC0699 | Arc-1502 | Highly potent CK2α inhibitor (K(i) = 0.5 nM), revealing high selectivity for CK2α in a panel of 140 protein kinases |
|
| DCC0700 | Arc-3002 | Highly potent and selective fluorescent probe of Rho kinase (ROCK) |
|
| DCC0701 | Arcapillin | Anticancer agent, inducing apoptosis mediated at least in part by the ERS pathway and inhibiting hepatoma tumor growth |
|
| DCC0702 | Arcc-4nc | Negative control for ARCC-4, binding androgen receptors (AR) without inducing degradation. |
|
| DCC0703 | Arformoterol Hydrochloride | Long-acting beta-2 adrenergic agonist |
|
| DCC0704 | Arformoterol Maleate | Long-acting beta-2 adrenergic agonist |
|
| DCC0705 | Arg-arg-leu | Potent tumor-homing tripeptide, targeting heat shock protein 70 (HSP70) |
|
| DCC0706 | ari-3531 | Novel selective inhibitor of PREP, displaying great selectivity over FAP, while also not inhibiting the DPPs. |
|
| DCC0707 | arkin-1 | Novel inhibitor of Ark1, the fission yeast member of the conserved Aurora kinase family |
|
| DCC0708 | Arl-67085 | P2T (P2YADP) purinoceptor antagonist |
|
| DCC0709 | Arl-67156 | Selective ecto-ATPase inhibitor, preventing metabolism of P2 purinoceptor agonists |
|
| DCC0710 | Armeniaspirol A | Natural inhibitor of recombinant purified ClpXP and ClpYQ AAA+ proteases, exhibitung potent antibacterial activity against H. pylori, including multidrug-resistant strains |
|
| DCC0711 | Armillarisin A | Regulator and promotor of immune functions, enhancing the role of macrophages, inhibiting bacteria growth, improving the protein metabolism, and regulating liver function |
|
| DCC0712 | Arn2508 | Novel dual inhibitor of the fatty acid amide hydrolase (FAAH) and the cyclooxygenase (COX) enzymes |
|
| DCC0713 | Arn-810 Analog | Novel selective estrogen receptor degrader (SERD), inducing regression in a tamoxifen-resistant breast cancer xenograft |
|
| DCC0714 | Arq736 | Novel potent and selective BRAF inhibitor |
|
| DCC0715 | ar-r17779 | Selective alpha-7 agonist |
|
| DCC0716 | Arsai 1r | The first human arylsulfatase A reversible inhibitor, impairing mouse oocyte fertilization |
|
| DCC0717 | arvelexin | Inhibitor of the inflammatory responses via NF |
|
| DCC0718 | Arzoxifene Hydrochloride | Non-steroidal selective estrogen receptor modulator (SERM) |
|
| DCC0719 | As-0141 | Novel Potent and Selective Inhibitor of CDC7 Kinase for the Treatment of Solid Cancers |
|
| DCC0720 | As057278 | Inhibitor of D-amino acid oxidase (DAAO) |
|
| DCC0721 | As1069562 | Inhibitor of serotonin (5-HT) and norepinephrine (NE) reuptake, significantly restoring decreased insulin-like growth factor 1 and fibroblast growth factor 2 mRNA levels in dorsal root ganglion and spinal cord, respectively |
|
| DCC0722 | As1468240 | Potent factor Xa inhibitor with significant oral anticoagulant activity |
|
| DCC0723 | as1669058 | Novel GPR119 agonist, potentiating insulin secretion from rat islets and having potent anti-diabetic effects in ICR and diabetic db/db mice |
|
| DCC0724 | As1670542 | Second-generation potent orally-active thrombopoietin (TPO) receptor agonist |
|
